Zacks Investment Research
24 Jul 2026, 18:41 UTC · 2h ago
Vertiv to Report Q2 Earnings: Buy, Sell, or Hold the VRT Stock?
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
24 Jul 2026, 18:41 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Vertiv (VRT) expects Q2 2026 adjusted earnings per share to be between $1.37 and $1.43, representing 44% to 51% year-over-year growth. — High projected growth in earnings typically drives positive price action for the specific stock.
+0.60Vertiv expects Q2 2026 revenues to range between $3.25 billion and $3.45 billion, with organic net sales increasing by 20% to 24%. — Strong revenue guidance reinforces the company's growth trajectory and demand for its AI-driven infrastructure.
+0.50Vertiv has beaten the Zacks Consensus Estimate in each of its last four trailing quarters, with an average surprise of 14.65%. — A consistent history of earnings beats increases investor confidence in the company's ability to meet or exceed current guidance.
+0.30Which stocks this story touches
Continue reading
6 related stories
Top 3 movers · tap to explore
Strong revenue and earnings growth projections, consistent earnings beats, and AI-driven order growth.
Mentioned as a partner of Vertiv and appears in high-page-view lists, indicating general positive market interest.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
2h ago
